An intranasal ASO therapeutic targeting SARS-CoV-2 | Nature...
the in vivo replication rate of B.1.427 was significantly lower than that of B.1.351, however, the viral titers of both variant strains were repressed to a similar degree by LNA ASO treatment (Fig.5b, d). Of note,